Animal Models in Vaccine Development: Key Contributors to Global Health 🦠🐭
Created on 2024-10-31 20:35
Published on 2024-11-01 15:00
Animal models have been indispensable in the rapid development of
vaccines, especially highlighted during the COVID-19 pandemic. These
models have allowed researchers to understand the pathogenesis of
SARS-CoV-2, evaluate the efficacy of vaccine candidates, and ensure
their safety before proceeding to human trials.
Role of Animal Models in Vaccine Research: Animal models, such as
mice, ferrets, and non-human primates, have been crucial in mimicking
the clinical symptoms and immune responses seen in humans infected with
SARS-CoV-2. These models help in understanding the disease\’s
transmission dynamics and pathogenesis, which are essential for
developing effective vaccines and therapeutics.
Lessons from COVID-19 Vaccine Development:
1. Rapid Adaptation and Testing: The adaptation of SARS-CoV-2 in
animal models like BALB/c mice has been pivotal. For instance, the
N501Y mutation in the spike protein allowed the virus to infect
mice, facilitating the study of neutralizing antibodies and vaccine
candidates.
2. Diverse Models for Comprehensive Understanding: Utilizing a
variety of animal models, including mice, hamsters, ferrets, and
non-human primates, has provided a broad understanding of the
virus\’s behavior and the immune response it elicits.
3. Preclinical Validation: Animal models have been essential for
the preclinical validation of vaccine candidates, ensuring that they
are both safe and effective before moving to human trials. This step
is crucial to mitigate risks and enhance the chances of sucess in
clinical phases.
4. Ethical Considerations: The urgency of the pandemic led to some
vaccine candidates bypassing animal trials to expedite human
testing. While this approach was justified given the circumstances,
it underscored the importance of animal models in predicting human
outcomes and highlighted the ethical debates surrounding their use.
In conclusion, animal models have been and will continue to be a
cornerstone in vaccine development, providing critical insights and
ensuring the safety and efficacy of vaccines before they reach humans.
The lessons learned from the COVID-19 pandemic emphasize the need for
continued refinement and ethical consideration in the use of these
models.
👉 What lessons from COVID-19 vaccine development stand out to you?
\#VaccineDevelopment \#AnimalResearch \#BiomedicalResearch
\#Immunology \#LaboratoryAnimals \#COVID19 \#GlobalHealth
References
———-
Animal models for studying COVID-19, prevention, and therapy: Pathology
and disease phenotypes. Veterinary Pathology, 59, 516 – 527.
<https://doi.org/10.1177/03009858221092015>.
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
Science (New York, N.y.), 369, 1603 – 1607.
<https://doi.org/10.1126/science.abc4730>.
Animal models for COVID-19. Nature, 586, 509 – 515.
<https://doi.org/10.1038/s41586-020-2787-6>.
COVID-19 Animal Models and Vaccines: Current Landscape and Future
Prospects. Vaccines, 9. <https://doi.org/10.3390/vaccines9101082>.
Advances and gaps in SARS-CoV-2 infection models. PLoS Pathogens, 18.
<https://doi.org/10.1371/journal.ppat.1010161>.
COVID and Animal Trials: A Systematic Review. *Journal of Pharmacy &
Bioallied Sciences*, 13, S31 – S35.
<https://doi.org/10.4103/jpbs.JPBS_749_20>.
A Meta-Analysis of Rhesus Macaques (Macaca mulatta), Cynomolgus Macaques
(Macaca fascicularis), African green monkeys (Chlorocebus aethiops), and
Ferrets (Mustela putorius furo) as Large Animal Models for COVID-19..
Comparative medicine. <https://doi.org/10.30802/AALAS-CM-21-000032>.
ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for
Vaccines and Therapeutics. Cell Host & Microbe, 28, 646 – 659.
<https://doi.org/10.1016/j.chom.2020.09.016>.
Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife:
advances and prospects in the development of animal models for vaccine
and therapeutic research. Human Vaccines & Immunotherapeutics, 16,
3043 – 3054. https://doi.org/10.1080/21645515.2020.1807802.
Current global vaccine and drug efforts against COVID-19: Pros and cons
of bypassing animal trials. Journal of Biosciences, 45.
<https://doi.org/10.1007/s12038-020-00053-2>.